RESUMO
Background: endometriosis, can cause ovarian conflict and reduced ovarian reserve that could lead to lower response to assisted reproductive techniques
Objective: current study was conducted to determine the association between level of anti-mullerian hormone [AMH] and the infertility treatment outcomes in infertile females with endometriosis versus the non-endometriosis infertile subject
Materials and Methods: in this case-control study, 64 infertile females who referred to Shariati Hospital from April 2015 to November 2017 were enrolled. They were divided in two groups of 32 patients [endometriosis and non-endometriosis women]. The anti-mullerian hormone level among all subjects was determined, treatment outcomes were evaluated and association between these factors was assessed
Results: it was seen that the anti-mullerian hormone [p=0.06], the number of retrieved oocytes [p=0.7] and embryos [p=0.7], implantation rate [p=0.6] and clinical pregnancy rate [p=0.9] were similar between two groups. In patients with stage 3 or 4 endometriosis who had lower serum AMH level significantly [p=0.001] less oocytes were retrieved [p=0.001] and less transferrable embryos [p=0.03] were achieved. However, implantation and pregnancy rates did not differ [p=0.7] [p=0.6]
Conclusion: totally, according to the obtained results, it may be concluded that ovarian reserve has more significant role in predicting infertility treatment outcome rather than receptive endometrium